Strategy Set to Report Q4 Earnings: Buy, Sell or Hold the Stock?
zacks.com
Want to monitor RNAC?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor RNACselecta biosciences, inc. is a clinical-stage biopharmaceutical company that is focused on unlocking the full potential of biologic therapies by mitigating unwanted immune responses. selecta plans to combine its tolerogenic synthetic vaccine particles (svp™) to a range of biologics for rare and serious diseases that require new treatment options.